姑息治疗对进行性神经系统疾病的效果:系统综述与荟萃分析
与常规照护相比,姑息治疗与更低的症状负担及更高的照护者和患者满意度相关,但在排除高偏倚风险研究后关联不显著;对患者生活质量和照护者负担的关联不显著。
要点
- 姑息治疗可能降低进行性神经系统疾病患者的症状负担。
- 姑息治疗可能提高患者和照护者的照护满意度。
- 对生活质量和照护者负担的影响尚不确定。
核心结论
- 姑息治疗可能改善进行性神经系统疾病患者及照护者的症状负担和照护满意度,但对生活质量和照护者负担的影响尚无定论。
研究设计与样本
- 系统综述与荟萃分析,纳入随机对照试验和准实验研究(包括预试验),检索MEDLINE、EMBASE、CINAHL PLUS、Cochrane CENTRAL和PubMed从建库至2021年9月。
主要发现
- 与常规照护相比,姑息治疗与更低的症状负担相关[SMD -0.34(95%CI -0.59至-0.09)]。
- 姑息治疗与更高的照护者满意度[SMD 0.41(95%CI 0.12至0.71)]和患者满意度[SMD 0.43(95%CI -0.01至0.87)]相关。
- 排除高偏倚风险研究后,上述关联均不显著。
- 姑息治疗与照护者负担[SMD -0.09(95%CI -0.21至0.03)]和患者生活质量[SMD 0.19(95%CI -0.07至0.44)]的关联不显著。
关键数值与推荐
- 纳入对象为患有进行性神经系统疾病(痴呆、多发性硬化、帕金森病、运动神经元病、多系统萎缩和进行性核上性麻痹)的成人及其照护者。
- 跨学科团队、姑息治疗医师、家庭访视和灵性照护等特定干预组分似乎与改善姑息结局的效果增加相关。
临床怎么用
- 对进行性神经系统疾病患者可考虑整合姑息治疗以改善症状负担和照护满意度。
- 需更多严格设计的研究探讨神经姑息治疗的效果、有效干预组分、最佳时机及转诊的症状触发因素。
局限性
- 排除高偏倚风险研究后关联不显著,提示结果可能受偏倚影响。
- 对生活质量和照护者负担的影响尚不确定。
- 需要更多严格设计的研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the association of palliative care for progressive neurologic diseases with patient- and caregiver-centered outcomes. DESIGN: Systematic review and meta-analysis of randomized controlled trials and quasi-experimental studies, including pilot studies. SETTING AND PARTICIPANTS: Adults with progressive neurologic diseases (dementia, multiple sclerosis, Parkinson's disease, motor neuron disease, multiple system atrophy, and progressive supranuclear palsy) and their caregivers. METHODS: MEDLINE, EMBASE, CINAHL PLUS, Cochrane CENTRAL, and PubMed were searched from inception to September 2021. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Cochrane risk of bias tools. Narrative synthesis was conducted. Patient quality of life (QoL), symptom burden, caregiver burden, and satisfaction with care were meta-analyzed using a random-effects model. RESULTS: Fifteen trials provided data on 3431 patients (mean age, 73.9 years). Compared with usual care, palliative care was statistically significantly associated with lower symptom burden [standardized mean difference (SMD), -0.34 (95% Cl, -0.59 to -0.09)] and higher caregiver satisfaction [SMD, 0.41 (95% Cl, 0.12 to 0.71)] and patient satisfaction [SMD, 0.43 (95% Cl, -0.01 to 0.87)]. However, the associations were not significant after excluding studies with high risk of bias. Insignificant associations of palliative care with caregiver burden [SMD, -0.09 (95% Cl, -0.21 to 0.03)] and patient QoL [SMD, 0.19 (95% Cl, -0.07 to 0.44)] were observed. CONCLUSIONS AND IMPLICATIONS: Palliative care is likely to improve symptom burden and satisfaction with care among patients with progressive neurologic diseases and their caregivers, while its effects on QoL and caregiver burden remains inconclusive. Specific intervention components including interdisciplinary team, palliative care physicians, home visits, and spiritual care appeared to be associated with increased effects on improving palliative outcomes. More rigorous designed studies are warranted to examine the effects of neuropalliative care, effective intervention components, optimal timing, and symptom triggers of palliative care referrals.
引用
- Chan LML, Yan OY, Lee JJJ, et al. Effects of Palliative Care for Progressive Neurologic Diseases: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2022. PMID: 36481217. doi:10.1016/j.jamda.2022.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。